Physician Assistant · Dallas, TX
NPI
1578936894
Since 2015
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5323 Harry Hines Blvd
Dallas, TX, 75390
Phone (214) 645-2800
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$80K
528 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Chelsea L Petro prescribed most often to Medicare patients was Prednisone, with 40 prescriptions and refills. In total Chelsea L Petro wrote 528 Medicare prescriptions that cost $80K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisone Generic | 40 | 54 | 18 | $259 |
| Tacrolimus Generic | 33 | 45 | 12 | $1,533 |
| Azithromycin Generic | 21 | 29 | Under 11 | $106 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 21 | 21 | 19 | $178 |
| Warfarin Sodium Generic | 20 | 20 | 11 | $91.92 |
| Mycophenolate Mofetil Generic | 20 | 27 | Under 11 | $728 |
| Valganciclovir Hcl Generic | 19 | 28 | Under 11 | $25K |
| Colistimethate Colistin (Colistimethate Na) | 17 | 17 | Under 11 | $2,985 |
| Metoprolol Tartrate Generic | 15 | 21 | Under 11 | $44.12 |
| Amphotericin B Liposome Generic | 13 | 13 | Under 11 | $8,303 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 11 | 11 | Under 11 | $14.04 |
| Sodium Chloride 0.9 % Sodium Chloride | 11 | 11 | Under 11 | $582 |
| Tramadol Hcl Generic | 11 | 11 | Under 11 | $19.63 |
Brand drugs: - claims; generic drugs: 471 claims; opioid claims: 12.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Chelsea L Petro were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.